Overview

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to preliminarily evaluate the efficacy and safety of chemotherapy plus subsequent loco-regional radiotherapy combined with toripalimab for the de novo metastatic nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University